Dobrzanski et al., J Immunol 2004
(Lung Neoplasms...) :
Moreover, both Tc2 and Tc1 effector cell therapies were dependent in part on recipient derived IFN-gamma and TNF-alpha for long-term survival and protection
Brignone et al., J Immunol 2007
:
In contrast to IMP321, TLR1-9 agonists induce IL-10 and are therefore unable to induce this Tc1 IFN-gamma+ response
Sasaki et al., Eur J Immunol 2008
(Melanoma, Experimental) :
Notably, the inhibitory effects of IL-4 on Tc1 expression of VLA-4 could be blocked by the presence of IL-12, but not IFN-gamma